Ji, Yan

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology. [electronic resource] - Clinical and translational science 07 2018 - 345-351 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review

1752-8062

10.1111/cts.12540 doi


Antineoplastic Agents, Immunological--administration & dosage
Clinical Trials, Phase II as Topic--standards
Clinical Trials, Phase III as Topic--standards
Dose-Response Relationship, Drug
Drug Development--standards
Humans
Maximum Tolerated Dose
Medical Oncology--standards
Neoplasms--drug therapy
United States
United States Food and Drug Administration--standards